Jing Liu

24PUBLICATIONS
11CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Biologically active moleculesPharmacogenomicsCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jun 17, 2026
Discovery of Dihydropyrimido-Pyrimidine-Based Bone Marrow Tyrosine Kinase Gene in Chromosome X Protein Proteolysis-Targeting Chimeras for the Treatment of Prostate Cancer.

|Mar 31, 2026
Timosaponin AIII enhances CAR-T cell potency and prevents relapse through impairing CAR-Tregs.

Mingqi Hou, Wenjun Zhang, Ziping Qi

|Oct 13, 2025
Discovery of a 1<i>H</i>-Pyrazol-3-Amine Derivative as a Novel, Selective, and Orally Available RIPK1 Inhibitor for the Treatment of Inflammatory Disease.

Qiangqiang Tao, Xixiang Li, Hongwei Yu

|Oct 13, 2025
Discovery of Novel Purine Derivatives as Potent and Orally Bioavailable PGK1 Inhibitors for the Treatment of Inflammatory Bowel Disease.

Zhi Huang, Juan Ge, Yongfei Chen

|May 19, 2025
Discovery of IHMT-15130 as a Highly Potent Irreversible BMX Inhibitor for the Treatment of Myocardial Hypertrophy and Remodeling.

Shuang Qi, Jiangyan Cao, Ting Wu

|Apr 08, 2025
Discovery of a Novel Dihydroisoquinolinone Derivative as a Potent CDK9 Inhibitor Capable of Overcoming L156F Mutant for the Treatment of Hematologic Malignancies.

Chenliang Shi, Yun Wu, Fengming Zou

Pageof 4

Frequent Collaborators

21 joint publications

Qingsong Liu

5 joint publications

Xiaofei Liang

2 joint publications

Shugeng Cao

2 joint publications

Ellen L Weisberg